Paul Secrist
2020
In 2020, Paul Secrist earned a total compensation of $513.3K as Chief Scientific Officer at Cyteir Therapeutics.
Compensation breakdown
| Bonus | $25,000 |
|---|---|
| Non-Equity Incentive Plan | $67,456 |
| Option Awards | $248,104 |
| Salary | $172,769 |
| Total | $513,329 |
Secrist received $248.1K in option awards, accounting for 48% of the total pay in 2020.
Secrist also received $25K in bonus, $67.5K in non-equity incentive plan and $172.8K in salary.
Rankings
In 2020, Paul Secrist's compensation ranked 10,959th out of 13,090 executives tracked by ExecPay. In other words, Secrist earned more than 16.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,959 out of 13,090 | 16th |
Division Manufacturing | 4,678 out of 5,621 | 17th |
Major group Chemicals And Allied Products | 1,942 out of 2,254 | 14th |
Industry group Drugs | 1,699 out of 1,954 | 13th |
Industry Pharmaceutical Preparations | 1,256 out of 1,459 | 14th |
Source: SEC filing on April 29, 2022.
Secrist's colleagues
We found two more compensation records of executives who worked with Paul Secrist at Cyteir Therapeutics in 2020.